Live Broadcast to Explore a Second Line Treatment Option for HER2+ Metastatic Breast Cancer

Article

In an upcoming broadcast, Joyce O'Shaughnessy, MD, Shanu Modi, MD, and Anne O’Dea, MD will discuss the approach and goals of the management of certain patients with HER2+ metastatic breast cancer (mBC) and take a deeper look at the burden and unmet needs of the disease. Additionally, they will discuss a second line treatment option for HER2+ mBC.

To obtain expert perspective and learn about the efficacy and safety data of this treatment option, watch the live broadcast on 6/16/2022. To register for the event, visit https://studio.mjhassoc.com/reach/2L-HER2Pos-mBC.

PP-US-ENB-1270 05/22

Related Videos
A panel of 4 experts on bladder cancer
A panel of 4 experts on bladder cancer
Vijayakrishna Gadi, MD, PhD, and Megan Kruse, MD
A panel of 4 experts on colorectal cancer
A panel of 4 experts on colorectal cancer
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center